MedTrace Logo

Effects of Standing Desks and Intermittent Walking on Cognitive Fatigue

NCT07576413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2026-05-08

No results posted yet for this study

Summary

The objective of this randomized-controlled crossover design was to identify inter-individual responses to the use of sitting desks, standing desks and two minutes of walking after twenty-eight minutes of sitting on the performance of cognitive tasks and moods in healthy undergraduate and graduate students. Participants were randomly assigned to an order of interventions and were asked to perform 26 minutes of cognitive tasks followed by completing 2 minutes of surveys where they were asked about their moods. Following the 28 minute cognitive battery participants were given a 2 minute break. In the seated condition participants performed all tasks on a seated desk and had to remain seated for their 2 minute break. In the standing condition participants performed the entire battery standing and had to remain standing for the 2 minute break. In the intermittent walking condition, participants performed all tasks in a seated condition and for their 2 minute break, participants were asked to walk for 2 minutes at a pace that they felt comfortable.

Conditions

  • Sitting Position
  • Overexertion From Maintaining Prolonged Standing Position
  • Walking

Interventions

BEHAVIORAL

Performance of cognitive tasks

Participants performed a series of cognitive tasks on all 3 days

Sponsors & Collaborators

  • Clarkson University

    lead OTHER

Principal Investigators

  • Ali Boolani, PhD · Clarkson University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2018-12-15
Completion
2018-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576413 on ClinicalTrials.gov